First Page | Document Content | |
---|---|---|
Date: 2013-11-18 05:52:30Blood Coagulation system Anatomy CSL Behring Von Willebrand disease Factor VIII Coagulation CSL Limited Hereditary angioedema Haemophilia Factor IX Factor VII | News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesAdd to Reading ListSource URL: www.cslbehring.atDownload Document from Source WebsiteFile Size: 82,62 KBShare Document on Facebook |
REGULAR ARTICLE CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise na¨ıve and memory cells ´ ` 1DocID: 1tX4g - View Document | |
News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesDocID: 1qHpD - View Document | |
For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [AntihaemoDocID: 1oCE0 - View Document | |
13308 FT Factor VIII Plasma déficientDocID: 1odr2 - View Document | |
UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •DocID: 1kAcN - View Document |